PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
January 18, 2010Cochrane library407 citations

Continuous subcutaneous insulin infusion (CSII) versus multiple insulin injections for type 1 diabetes mellitus

View Full Paper
MMMarie MissoKEKristine J EgbertsMPMatthew J. Page

Key Points

Key points are not available for this paper at this time.

Abstract

There is some evidence to suggest that CSII may be better than MI for glycaemic control in people with type 1 diabetes. Non-severe hypoglycaemic events do not appear to be reduced with CSII. There is insufficient evidence regarding adverse events, mortality, morbidity and costs.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Misso et al. (2010) studied this question.

synapsesocial.com/papers/69d72aab3f906f6a06bef85fhttps://doi.org/10.1002/14651858.cd005103.pub2
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Near normoglycemia for 1 year has no effect on platelet reactivity, factor VIII, and von willebrand factor in insulin-dependent diabetes mellitus: A controlled trial1987 · 7 citations
  2. 2Accommodating Planned Exercise in Type I Diabetic Patients on Intensive Treatment1985 · 56 citations
  3. 3Autonomic and Somatosensory Nerve Function After 2 Years of Continuous Subcutaneous Insulin Infusion in Type I Diabetes1988 · 65 citations
  4. 4Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus1997 · 6,234 citations
  5. 5Physiology and Pathophysiology of Insulin Secretion1990 · 140 citations